US Bancorp’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

US Bancorp’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,224	Closed	-$90.3K	–	4309
2025 Q2	$90.3K	Hold	2,224	–	–	﹤0.01%	2474
2025 Q1	$97.4K	Hold	2,224	–	–	﹤0.01%	2411
2024 Q4	$95.6K	Buy	+2,224	New	+$101K	﹤0.01%	2414
2021 Q2	–	Sell	-556	Closed	-$28K	–	4086
2021 Q1	$28K	Hold	556	–	–	﹤0.01%	2879
2020 Q4	$29K	Buy	+556	New	+$26.6K	﹤0.01%	2747
2020 Q1	–	Sell	-1,350	Closed	-$62K	–	3811
2019 Q4	$62K	Buy	+1,350	New	+$53.5K	﹤0.01%	2374
2019 Q2	–	Sell	-154	Closed	-$6K	–	3683
2019 Q1	$6K	Hold	154	–	–	﹤0.01%	3213
2018 Q4	$6K	Buy	+154	New	+$6.57K	﹤0.01%	3178
2015 Q2	–	Sell	-1,500	Closed	-$93K	–	3652
2015 Q1	$93K	Hold	1,500	–	–	﹤0.01%	2205
2014 Q4	$81K	Hold	1,500	–	–	﹤0.01%	2276
2014 Q3	$80K	Hold	1,500	–	–	﹤0.01%	2240
2014 Q2	$78K	Hold	1,500	–	–	﹤0.01%	2265
2014 Q1	$70K	Hold	1,500	–	–	﹤0.01%	2317
2013 Q4	$66K	Hold	1,500	–	–	﹤0.01%	2314
2013 Q3	$58K	Buy	+1,500	New	+$56.7K	﹤0.01%	2283

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

US Bancorp's XPH Position: Q3 2025 in Review

US Bancorp sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2025, closing a stake of 2,224 shares — an estimated $90.3K sold.

US Bancorp first reported a position in XPH in Q3 2013 and held it in 15 quarters. The position peaked at $97.4K in Q1 2025. 69 funds tracked by Wall St. Rank hold XPH as of Q3 2025.

US Bancorp reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2025 after selling out during the quarter.
US Bancorp sold 2,224 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2025, an estimated $90.3K.
US Bancorp first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2013 and held it in 15 quarters.
US Bancorp's State Street SPDR S&P Pharmaceuticals ETF position peaked at $97.4K in Q1 2025.
69 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2025.

Based on US Bancorp's 13F filing for Q3 2025, filed 12 Nov 2025.